Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy
- PMID: 12368904
- DOI: 10.1038/nm778
Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy
Abstract
Hypertrophic growth is a risk factor for mortality in heart diseases. Mechanisms are lacking for this global increase in RNA and protein per cell, which underlies hypertrophy. Hypertrophic signals cause phosphorylation of the RNA polymerase II C-terminal domain, required for transcript elongation. RNA polymerase II kinases include cyclin-dependent kinases-7 (Cdk7) and Cdk9, components of two basal transcription factors. We report activation of Cdk7 and -9 in hypertrophy triggered by signaling proteins (Galphaq, calcineurin) or chronic mechanical stress. Only Cdk9 was activated by acute load or, in culture, by endothelin. A preferential role for Cdk9 was shown in RNA polymerase II phosphorylation and growth induced by endothelin, using pharmacological and dominant-negative inhibitors. All four hypertrophic signals dissociated 7SK small nuclear RNA, an endogenous inhibitor, from cyclin T-Cdk9. Cdk9 was limiting for cardiac growth, shown by suppressing its inhibitor (7SK) in culture and preventing downregulation of its activator (cyclin T1) in mouse myocardium.Note: In the AOP version of this article, the numbering of the author affiliations was incorrect. This has now been fixed, and the affiliations appear correctly online and in print.
Similar articles
-
Cyclin-dependent kinase-9: an RNAPII kinase at the nexus of cardiac growth and death cascades.Circ Res. 2004 Oct 29;95(9):867-76. doi: 10.1161/01.RES.0000146675.88354.04. Circ Res. 2004. PMID: 15514168
-
Cyclins that don't cycle--cyclin T/cyclin-dependent kinase-9 determines cardiac muscle cell size.Cell Cycle. 2003 Mar-Apr;2(2):99-104. Cell Cycle. 2003. PMID: 12695656 Review.
-
Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.EMBO J. 2004 Sep 1;23(17):3559-69. doi: 10.1038/sj.emboj.7600351. Epub 2004 Aug 5. EMBO J. 2004. PMID: 15297879 Free PMC article.
-
Upregulation of cyclin T1/CDK9 complexes during T cell activation.Oncogene. 1998 Dec 17;17(24):3093-102. doi: 10.1038/sj.onc.1202548. Oncogene. 1998. PMID: 9872325
-
Pharmacological targeting of CDK9 in cardiac hypertrophy.Med Res Rev. 2010 Jul;30(4):646-66. doi: 10.1002/med.20172. Med Res Rev. 2010. PMID: 19757441 Review.
Cited by
-
Mediator complex dependent regulation of cardiac development and disease.Genomics Proteomics Bioinformatics. 2013 Jun;11(3):151-7. doi: 10.1016/j.gpb.2013.05.002. Epub 2013 May 28. Genomics Proteomics Bioinformatics. 2013. PMID: 23727265 Free PMC article. Review.
-
Telomere attrition and Chk2 activation in human heart failure.Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5378-83. doi: 10.1073/pnas.0836098100. Epub 2003 Apr 17. Proc Natl Acad Sci U S A. 2003. PMID: 12702777 Free PMC article.
-
Identify Tcea3 as a novel anti-cardiomyocyte hypertrophy gene involved in fatty acid oxidation and oxidative stress.Front Cardiovasc Med. 2023 Jun 19;10:1137429. doi: 10.3389/fcvm.2023.1137429. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37404738 Free PMC article.
-
Viral-host interactions that control HIV-1 transcriptional elongation.Chem Rev. 2013 Nov 13;113(11):8567-82. doi: 10.1021/cr400120z. Epub 2013 Jun 24. Chem Rev. 2013. PMID: 23795863 Free PMC article. Review.
-
Ready, pause, go: regulation of RNA polymerase II pausing and release by cellular signaling pathways.Trends Biochem Sci. 2015 Sep;40(9):516-25. doi: 10.1016/j.tibs.2015.07.003. Epub 2015 Aug 4. Trends Biochem Sci. 2015. PMID: 26254229 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
